HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Kristen Hall Selected Research

beta- 1,3- galactosyl- 0- glycosyl- glycoprotein beta-1,3-N-acetylglucosaminyltransferase

4/2020Knockdown of N-Acetylglucosaminyltransferase-II Reduces Matrix Metalloproteinase 2 Activity and Suppresses Tumorigenicity in Neuroblastoma Cell Line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Kristen Hall Research Topics

Disease

6Neuroblastoma
05/2021 - 10/2011
2Neoplasms (Cancer)
01/2021 - 01/2018
1Nervous System Diseases (Neurological Disorders)
01/2017

Drug/Important Bio-Agent (IBA)

6Polysaccharides (Glycans)IBA
05/2021 - 10/2011
3Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2018
1Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
05/2021
1alpha-1,3-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase IIBA
01/2021
1beta- 1,3- galactosyl- 0- glycosyl- glycoprotein beta-1,3-N-acetylglucosaminyltransferaseIBA
04/2020
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
04/2020
1Glycoproteins (Glycoprotein)IBA
10/2011